Targeted Cancer Therapeutics: The NRG1 Fusion Market and Precision Oncology Innovations
Targeted cancer therapeutics represent the forefront of oncology, offering precise and effective treatment options for patients with genetically defined cancers. Among the most promising targets are NRG1 fusions, rare genetic alterations found in a small but significant subset of solid tumors. The targeted cancer therapeutics market is experiencing substantial growth, with projections...
0 Comments 0 Shares 50 Views 0 Reviews